| |
| |
|
| Insider
Information: |
Ekman Lars |
| Relationship: |
Director |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
17,988 |
|
|
Indirect Shares
|
520 |
|
|
| Direct
Value |
$786,284 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,508 |
|
|
| Total
Value |
$786,284 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-06-04 |
0 |
Premium* |
|
|
Sophiris Bio Inc. |
SPHS |
Director |
|
0 |
2014-12-18 |
520 |
Premium* |
|
|
Amarin Corp Plc |
AMRN |
Director |
2019-11-12 |
0 |
2013-11-20 |
0 |
Premium* |
|
|
Prothena Corp Plc |
PRTA |
Chair of the Board, Di... |
2023-01-03 |
243 |
2015-11-25 |
0 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
Director |
2022-06-24 |
17,745 |
2016-06-09 |
0 |
Premium* |
|
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2018-05-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRTA |
Prothena Corp Plc |
Chair of the Board |
– • – |
2023-01-03 |
4 |
AS |
$54.15 |
$886,407 |
D/D |
(15,834) |
243 |
0 |
% |
|
| PRTA |
Prothena Corp Plc |
Chair of the Board |
– • – |
2023-01-03 |
4 |
OE |
$6.41 |
$101,496 |
D/D |
15,834 |
16,077 |
0 |
- |
|
| PRTA |
Prothena Corp Plc |
Chair of the Board |
• • – |
2022-12-01 |
4 |
AS |
$61.28 |
$975,406 |
D/D |
(15,834) |
243 |
0 |
% |
|
| PRTA |
Prothena Corp Plc |
Chair of the Board |
• • – |
2022-12-01 |
4 |
OE |
$6.41 |
$101,496 |
D/D |
15,834 |
16,077 |
0 |
- |
|
| PRTA |
Prothena Corp Plc |
Chair of the Board |
• • – |
2022-11-01 |
4 |
AS |
$62.01 |
$995,658 |
D/D |
(15,833) |
243 |
0 |
% |
|
| PRTA |
Prothena Corp Plc |
Chair of the Board |
• • – |
2022-11-01 |
4 |
OE |
$6.41 |
$101,490 |
D/D |
15,833 |
16,076 |
0 |
- |
|
| PRTA |
Prothena Corp Plc |
Chair of the Board |
– • – |
2022-10-03 |
4 |
AS |
$60.32 |
$974,082 |
D/D |
(15,833) |
243 |
0 |
% |
|
| PRTA |
Prothena Corp Plc |
Chair of the Board |
– • – |
2022-10-03 |
4 |
OE |
$6.41 |
$101,490 |
D/D |
15,833 |
16,076 |
0 |
- |
|
| PRTA |
Prothena Corp Plc |
Chair of the Board |
• • – |
2022-09-28 |
4 |
OE |
$6.41 |
$202,979 |
D/D |
31,666 |
31,909 |
0 |
- |
|
| PRTA |
Prothena Corp Plc |
Chair of the Board |
• • – |
2022-09-28 |
4 |
AS |
$48.09 |
$1,522,818 |
D/D |
(31,666) |
243 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2022-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
17,745 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2021-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,145 |
14,445 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2019-12-17 |
4 |
D |
$114.50 |
$343,500 |
D/D |
(3,000) |
0 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2019-11-12 |
4 |
AS |
$19.35 |
$746,759 |
D/D |
(38,600) |
0 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2019-11-12 |
4 |
OE |
$14.40 |
$555,840 |
D/D |
38,600 |
38,600 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2019-11-05 |
4 |
AS |
$18.00 |
$115,230 |
D/D |
(6,400) |
0 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2019-11-05 |
4 |
OE |
$14.40 |
$92,160 |
D/D |
6,400 |
6,400 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2019-09-03 |
4 |
AS |
$15.01 |
$1,365,722 |
D/D |
(91,016) |
0 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2019-09-03 |
4 |
OE |
$3.06 |
$320,280 |
D/D |
91,016 |
91,016 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
Director |
– • – |
2019-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,750 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2019-05-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
3,000 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2019-03-04 |
4 |
AS |
$21.16 |
$2,884,905 |
D/D |
(135,377) |
0 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2019-03-04 |
4 |
OE |
$1.03 |
$276,743 |
D/D |
135,377 |
135,377 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2019-01-10 |
4 |
AS |
$14.92 |
$2,426,489 |
D/D |
(140,416) |
0 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2019-01-10 |
4 |
OE |
$1.03 |
$103,428 |
D/D |
100,416 |
140,416 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
